John Byrd, M.D., Ching-Shih Chen, Ph.D., Michael Freitas, Ph.D., Michael Grever, Ph.D., Samual Kulp, Ph.D., David Lucas, Ph.D., Mark R. Parthun, Ph.D., Amy Sklenar, B.S., Xiaodan Su, Ph.D.

Partially funded by Cardinal Health

Location: The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute - OH
Proposal: Chromatin regulation as a therapeutic target to enhance biologic therapies in Chronic Lymphocytic Leukemia (CLL)
Mailing List Mailing List
Close Mailing List